Dr. Sanjay P. Ahuja shares insight into Innovative Hematology’s Gene Therapy Hub, the first of its kind in Indiana.
Public News Service on MSN
In hemophiliac patients have innovative treatment option
Hemophilia, a genetic bleeding disorder that prevents the body from clotting blood, can turn a simple paper cut into a deadly bleeding episode. But Indiana residents suffering from the disease now ...
MRD testing promises sharper DLBCL response tracking than PET scans, cutting false positives, biopsies, and guiding therapy ...
Circulating tumor DNA levels a few weeks after immunotherapy initiation could help identify patients with melanoma at greatest risk for recurrence or death.A retrospective analysis showed individuals ...
A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors.
Retrospective cohorts show GLP-1 RA exposure yields ~5% relative weight reduction and an apparent OS advantage, while ...
This will be Prasad’s second exit from the FDA during the current Trump administration. In July, he resigned amid his controversial handling of a gene therapy treatment for Duchenne muscular dystrophy ...
Spherix Global Insights today announced the release of its 2026 Patient Chart Dynamix(TM): Sickle Cell Disease (US) report, an in-depth analysis of 133 real-world patient charts collected from 86 U.S.
FACE binds to CD71 on the T‑cell surface in CAR T cell preparation, and post-infusion, the same FACE molecules attach to CD71 on leukemia cells.
HealthDay News — In guidelines issued by the American Society of Hematology and published online Feb. 11 in Blood Advances, recommendations are presented for frontline management of acute ...
Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically engineering a chimeric antigen receptor on the surface of the patient's T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results